Looks like this event has already ended.
Check out upcoming events by this organizer, or organize your very own event.
Virtually every life sciences startup, investor, or research effort aims to challenge the status quo. But in New York, this unfolding story of disruption might be unparalleled. Perhaps nowhere in the country are scientists, entrepreneurs, non-profits, and investors doing more to not only shake up their fields, but also band together to build the city's life science innovation machine from the ground up. But what are their specific goals, and what is their approach to building great biotech companies and research programs? Which areas are being targeted? And how can this all get done in a city starved for a biotech startup culture, despite all its financial and industry power?
Join us for this unique, interactive evening featuring stories from some of the region's most radical life science leaders out to change the definition of New York biotech through broad academic-industry partnerships, advances in genomics, cancer research and rare diseases, and a new style of biotech-pharma dealmaking that extends across the life sciences world.
Ron Cohen, CEO, Acorda Therapeutics
Alex Denner, Founding Partner, Sarissa Capital Management
George Golumbeski, Senior Vice President of Business Development, Celgene
Francois Nader, President and Chief Executive Officer, NPS Pharmaceuticals
Eric Schadt, Director, The Icahn Institute for Genomics and Multiscale Biology
Marc Tessier-Lavigne, President, Rockefeller University
Meg Tirrell, Biotechnology Reporter, Bloomberg News
Registration: 4:30 - 5:30 pm
Program: 5:30 - 7:00 pm
Networking Reception: 7:00 - 8:00 pm
Tickets are transferable but not refundable.
To inquire about press registration, email email@example.com.
Alexandria Real Estate Equities
Biogen Idec • Cubist Pharmaceuticals
EisnerAmper • Genentech
Guard Dog Brand Development • Halloran Consulting Group
Kauffman Foundation • Kilpatrick Townsend
Latham & Watkins • Turnstone
VENTURE CAPITAL MEMBERS
Avalon Ventures • Boston Millennia Partners
LaunchCapital • Psilos Group • Rho Capital Partners
SR One • Third Rock Ventures
LIFE SCIENCE MEMBERS
Alnylam Pharmaceuticals • Infinity Pharmaceuticals
Ironwood Pharmaceuticals • Moderna Therapeutics
Harlem Biospace • NewYorkBio
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.